Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003742085 | SCV004500555 | pathogenic | Familial hypercholesterolemia | 2023-08-01 | criteria provided, single submitter | clinical testing | This variant, c.1374_1382del, is a complex sequence change that results in the deletion of 4 and insertion of 1 amino acid(s) in the LDLR protein (p.Arg458_Gly461delinsSer). For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the LDLR protein in which other variant(s) (p.Gly461Cys) have been determined to be pathogenic (PMID: 16465405, 35339733). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. This variant has not been reported in the literature in individuals affected with LDLR-related conditions. This variant is not present in population databases (gnomAD no frequency). |